drugset
drugset / Trial / NCT05930925

A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults

NCT05930925 ↗

Phase 1 Completed 12 enrolled Pfizer Arvinas Estrogen Receptor, Inc. · collab
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to understand how the study medicine ARV-471 is processed in the body of healthy males and females who do not have the potential to have children. This study is seeking for participants who: * are healthy males and females who do not have the potential to have children. * are 18 years of age or older. * weigh more than 110 pounds.

Timeline

Start
2023-06-12
Primary completion
2023-07-27
Completion
2023-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject vepdegestrant Other / unclassified — Oral

Indications

No indication recorded.